We conduct deep research on companies primarily in the emerging markets, looking for ideas that will generate excellent compound returns with a high margin of safety. I am the youngest analyst to win multiple awards in global contests sponsored by FactSet and Ira Sohn on the online buy-side platform SumZero.
I am currently a first-year MBA student at the Kellogg School of Management, seeking for an Equity Research internship position this summer.
I graduated with a master degree of control theory and control engineering from Northeastern University in China. My first job was a software engineer at Lucent Technologies, which fundamentally grew my interest in technology. At the same time I started investing in China‘s stock market. The 2007 stock market crash sparked my curiosity in finance, then I studied for CFA. Next, I transitioned to a business analyst at Thomson Reuters focusing on exchange-traded data across Asia Pacific. I enjoyed my broad exposure to the financial markets, and at the same time made huge efforts understanding the stock market. Overtime I developed my economic intuition and genuine interest in Equity Research. I am here at Kellogg in hoping to get my journey started with a strong platform in US.
Steven H. Goldman is a commercial litigation lawyer and senior partner in the Toronto law firm of Goldman Hine LLP. He is a former member of the board of directors of Tribute Pharmaceuticals Inc., a Canadian public pharmaceutical company which recently merged with Pozen Pharmaceuticals on February 5, 2016, and is now known as Aralez Pharmaceuticals (Nasdaq: ARLZ). He is currently on the board of directors of both Select Sands Corp. (TSX.V: SNS.V) as well as Comstock Metals Ltd. (TSX.V: CSL.V) which both trade on the TSX Venture exchange.
I am a writer and a photographer with an interest in self-guided investing. So you could say I am a student, not a teacher in this arena!
I read the financial pages daily and am rather skeptical of the conventional wisdom that served so many for so long, namely 50% bonds and 50% stocks or simply buy and hold forever. The world is changing rapidly and we are seeing things we never saw before, like multiple rounds of quantitative easing, indescribable debt and negative interest rates. As a baby boomer, these world facts stir up my inner unceratinties.
Still, the mattress option is not viable either.
I joined Seeking Alpha in 2016 and am deeply ...More
The approach is buy undervalued stocks & bonds, preferably long term income generating, and hold until the story changes. No options, no forex, no margin, no ETFs, no metals, and short maybe once a year on sure things only!
The sage points out the moon, the fool looks at the finger.